Actively Recruiting
Screening, Evaluation, and Assessment Protocol for Substance Use Disorder Research at NIDA Intramural Research Program
Led by National Institute on Drug Abuse (NIDA) · Updated on 2026-06-03
10000
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying people with and without alcohol and substance use disorders (ASUD) to better understand why some use drugs, stop using them, avoid addiction, or never use them at all. This observational study is conducted by the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) and aims to improve knowledge and develop treatments for ASUD. It focuses on evaluating participants to determine their eligibility for other ongoing research studies at NIDA. Participants will undergo a thorough screening and evaluation process lasting up to 8 hours, which may be split across multiple days depending on individual interest and study requirements. The assessments include physical exams, various biological tests (blood, saliva, urine, breath), heart function tests, smell tests, cognitive and mental health evaluations, questionnaires about substance use and medical history, and mock MRI scans. This protocol serves as the initial step to identify individuals eligible for further NIDA research studies. During the study, participants will complete one or more visits for screening and evaluation. Researchers will collect detailed data on substance use, mental and physical health, and cognitive function through tests and questionnaires. This data will be used to create a registry of potential research participants and to support future analyses aimed at understanding addiction, abstinence, and related outcomes. The study allows participation of adults aged 18 to 99 years and includes people with current, past, or no history of substance use disorders.
CONDITIONS
Brief Title
Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 99 years old
- Ability to read, write, and understand English
- Willingness to comply with all screening procedures
- Availability for the duration of the screening period
- Ability and willingness to sign a written informed consent document
You will not qualify if you...
- Lack of capacity to consent to research participation as determined by the Evaluation to Sign Consent (ESC)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
One or more visits
Trial Site Locations
Total: 1 location
1
National Institute on Drug Abuse
Baltimore, Maryland, United States, 21224
Actively Recruiting
Research Team
S
Shannon M Pfistner
L
Lorenzo Leggio, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2